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1. Introduction 
In the cotirse of our pursuit of the physiological 
receptor for acetylcholine (ACh) we have studied, by 
equilibrium dialysis, the reversible binding of ACh to 
membrane fragments i olated from electric tissue of 
Electrophorus electricus. In this letter we show that 
under conditions where acetylcholinesterase (AChE) 
is inhibited by eserine (physostigrnine) the reversible 
binding of ACh to a protein present in the membrane 
fragments can be demonstrated. This protein is iden- 
tified as AChE. 
2. Methods 
Membrane fragments derived from the innervated 
face of electroplax cells were purified by sucrose 
gradient centrifugation after homogenisation f 
fresh electric tissue from E. electricus. Pure AChE 
(specific activity: 770 mmoles Ach/mg/h) was pre- 
pared from the same tissue by the method of Leuzin- 
ger and Baker [l] . Equilibrium dialysis experiments 
were performed at room temperature following 
exactly the technique used by Gilbert and MUller-Hill 
for the isolation of the Luc repressor [2]. Routinely 
the extracts were first dialysed against 10m5 eserine in 
low3 M Na phosphate pH 7.0 in order to inhibit 
AChE. The bags were then equilibrated for one to 
two hours with a solution of radioactive ACh in the 
same medium. Bound ACh was estimated by measur- 
ing the radioactivity of the bag content and of the 
external fluid. Proteins were assayed by the method 
of Folin. 
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3. Results and discussion 
Fig. 1 and table 1 show that ACh strongly binds to 
membrane frawents in the presence of 1 0w5 .M eserine 
in 10e3 M Na phosphate pH 7.0. A similar effect is ob- 
served when phospholine (diisopropyl-phosphoryl- 
thiocholine) is used instead of eserine for the inhibi- 
tion of AChE. As indicated on table 1 the membrane 
component which accounts for ACh binding is inac- 
tivated by a 15 min exposure at 60°C and by a one 
hour incubation at pH 2.0 or 12.0; it is digested by 
pronase but resists to pancreatic lipase, trypsin and 
chymotrypsin. This component is thus a protein. In 
order to identify this protein we centrifuged mem- 
brane fragments dissolved in 1% deoxycholate on top 
of a sucrose gradient established in 1 O-3 M Na phos- 
phate pH 7.0 supplemented with l%odeoxycholafe. 
Both ACh binding and AChE activity were assayed in 
each fraction collected after centrifugation. Fig. 2 
shows that the ACh binding protein sediments at 
exactly the same velocity as AChE. 
We therefore tested the binding of ACh to pure 
AChE prepared from electric tissue and found, in- 
deed, that the pure protein binds ACh in the presence 
of 10” M eserine. In fig. 1 the binding curves of ACh 
to both membrane fractions and pure AChE are com- 
pared; the two curves superimpose almost exactly. 
A striking quantitative feature of ACh binding to 
AChE is that, in the present experimental conditions, 
the binding curve does not follow a simple Langmuir 
isotherm; there is no tendency for saturation at high 
ACh concentration; above lo4 M free ACh the 
amount of bound ACh increases almost linearly with 
the concentrations of free ACh; the Scatchard plot of 
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Fig. 1. Binding of ACh to membrane fragments and pure AChE both from electric tissue. Left: ACh bound per g protein is plotted 
as a function of free ACh concentrations. Right: Scatchard plot of the binding data relative to pure AChE; rACh is the number of 
ACh molecules bound per molecule of AChE (M.W. = 2.6 X 105) [6] and c is the free concentration of ACh expressed in moles 
per liter. AChE concentrations are estimated spectrophotometrically (E = 16.1 [7] ) and chemically (Folin reaction, and biuret). 
Table 1 
Some properties of the membrane component binding ACh 
in the presence of eserine. 
Bound ACh 
% control 
10m6 M phospholine 
instead of 10m5 M eserine * 
heated at 60°C for 15 min 
0.5 mg/ml pronase, 1 hr 
0.5 mg/ml pancreatic lipase, 1 hr 
0.5 mg/ml chymotrypsin, 1 hr 
0.5 mg/ml trypsin, 1 hr 
pH 2.0, 1 hr 
pH 12.0, 1 hr 
1% Na deoxycholate * 
1% Mton Xl00 * 
10m2 M NaCl * 
10-l M NaCl * 
104 M TDF, .l hr, pH 7.0 
56. 
4.5 
13.2 
120. 
91. 
86. 
< 0.1 
4.15 
0.39 
139. 
19.2 
<O.l 
24.5 
Except when indicated by * the indicated treatment was per- 
formed on membrane fractions before measurement of ACh 
binding in the standard conditions. When indicated by * the 
dialysis was done in the presence of the effector. Membrane 
fractions usually contain from 2 to 9 mg of protein per ml. 
The free concentration of ACh was 10-6 M. 
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Fig. 2. Sedimentation in sucrose gradient of membrane frag- 
ments treated with 1% deoxycholate. Sodium deoxycholate 
is first added at room temperature for a few minutes to the 
suspension of membrane fragments in sucrose containing 
9.2 mg protein per ml. The mixture is then dialysed against 
1% deoxycholate in low3 M Na phosphate, pH 7.0, for 1 hr 
and added on top of a sucrose gradient stabilized in 10e3 M 
Na phosphate, pH 7.0, supplemented with 1% deoxycholate. 
The gradients are centrifuged for 4 hr at 50,000 rpm in a 
SW 65 rotor in a Beckman Spinco preparative ultracentrifuge. 
AChE and ACh binding in the presence of 10e5 M eserine 
are measured following the procedure described in section 2. 
Initial rates of acetylthiocholine hydrolysis (vi) are expressed 
in mmoles/min/fil of fraction. 
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Fig. 3. Antagonism of ACh binding to pure AChE by d-tubo- 
curarine and decamethonium. The free concentration of ACh 
in the absence of effector was lo6 M. The concentration of 
enzyme was 1.2 X 10V3 M. 
the binding data is not linear and does not extrapolate 
to a finite number of sites at infinite ligand concentra- 
tion (fig. 1). Furthermore at high ACh concentrations 
the number of ACh molecules bound per molecule of 
AChE becomes remarkably large, values up to several 
hundred are found. This result is not accounted for 
simply by our present knowledge of AChE quaternary 
structure (01s~ dimer) [3]. The apparent number of 
ACh binding sites measured in these conditions is 
several orders of magnitude larger than the number of 
AChE protomers. 
However, ACh bound to AChE is displaced by com- 
pounds pharmacologically active in the electroplax 
preparation [4] , such as decamethonium, a depolariz- 
ing agent (or receptor activator), d-tubocurarine and 
flaxedil, two reversible receptor inhibitors (fig. 3). 
Preincubation of AChE with p-(trimethylammonium) 
benzene diazonium fluoroborate (TDF), an irreversible 
receptor inhibitor [5], is followed by a dramatic loss 
of its capacity to bind ACh. Furthermore, as shown in 
table 1 for NaCl, ACh binding is considerably reduced 
in the presence of high salt concentrations (10-l M 
NaCl, 10m3 M CaCl, or MgCl,) or of a negatively 
charged detergent (1% Na deoxycholate) but remains 
unchanged or slightly increases in the presence of a 
non ionic detergent (l%o Triton X100). The Binding 
of ACh in the presence of eserine seems thus to in- 
volve a special class of sites, distinct from AChE cata- 
lytic sites, which present a high affinity for curare-like 
agents. The positive charge of the ACh molecule is 
essential for the interaction of ACh with these sites. 
Of importance is the observation that this unusual 
capacity for ACh binding appears to be a specific 
property of AChE. First of all, the total amount of 
ACh bound by the membrane fragments is completely 
accounted for by their content in AChE, estimated 
through an enzyme test (about 5% w/w of the total 
protein). Furthermore four unrelated proteins tested 
in the same conditions, serum albumin, fl-galactosi- 
dase, ribonuclease, and catalase, do not show any sig- 
nificant binding of ACh. 
Neither the physicochemical interpretation nor 
the physiological significance of this unique property 
of AChE are yet clear. An attractive hypothesis re- 
lates it to the previously suggested function of AChE 
as the macromolecular receptor of ACh through regu- 
Zatory sites, distinct from its catalytic centre, but 
specific for quaternary nitrogen-containing compounds 
[6]. However, the correlation of this molecular prop- 
erty of AChE to the in vivo pharmacological effects 
observed with the entire cell has not yet been done; 
in addition it is not excluded that other ACh binding 
proteins distinct from AChE might be present in small 
amounts in the extract and remain undetected in the 
present experimental approach. 
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